Average Co-Inventor Count = 2.57
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (3 from 832,761 patents)
2. Institut National De La Sante Et De La Recherche Medicale (3 from 1,743 patents)
3. Universitë De Bordeaux (3 from 203 patents)
4. Op2 Drugs (3 from 3 patents)
5. Centre Hospitalier Universitaire De Bourdeaux (2 from 2 patents)
6. Centre Hospitalier Universitaire De Bordeaux (1 from 20 patents)
6 patents:
1. 11554106 - Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of miochondrial origin
2. 11484529 - Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
3. 11400073 - Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin
4. 11318113 - Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
5. 10653668 - Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production
6. 10272066 - Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production